Exane Asset Management Takeda Pharmaceutical CO LTD Transaction History

Exane Asset Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 21, 2021	SELL	$16.71 - $19.9 $659,343 - $785,214	-39,458 Closed	0 $0
Q4 2020 Jan 22, 2021	SELL	$15.39 - $18.97 $209,827 - $258,636	-13,634 Reduced 25.68%	39,458 $718,000
Q4 2019 Feb 03, 2020	SELL	$16.88 - $20.83 $161,136 - $198,843	-9,546 Reduced 15.24%	53,092 $1.05 Million
Q3 2019 Oct 24, 2019	SELL	$16.15 - $17.99 $3.51 Million - $3.91 Million	-217,362 Reduced 77.63%	62,638 $1.08 Million
Q2 2019 Aug 05, 2019	SELL	$16.58 - $20.49 $2.49 Million - $3.08 Million	-150,369 Reduced 34.94%	280,000 $0

Q1 2019 May 07, 2019	SELL	$16.7 - $21.52 $8.4 Million - $10.8 Million	-503,097 Reduced 53.9%	430,369 $0
Q4 2018 Feb 05, 2019	BUY	$15.64 - $21.1 $14.6 Million - $19.7 Million	933,466 New	933,466 $15.7 Million

341

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.1B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Exane Asset Management, based on Form 13F filings with the SEC.

Stay updated on Exane Asset Management with notifications on news.